Auris Medical Holding (EARS) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Auris Medical Holding AG Reports First Quarter 2015 Financial Results and Provides Business Update
May 28, 2015 6:50 AM EDTZUG, Switzerland, May 28, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (Nasdaq: EARS) today provided an update on the Company's business and announced financial results for the first quarter ended March 31, 2015.
"Auris Medical continued to make strong progress in the first months of 2015," commented Thomas Meyer, the Company's founder, Chairman and CEO. "Enrollment into our AM-101 Phase 3 trials in the treatment of acute inner ear tinnitus advanced well, and through our recent equity raise we laid the groundwork for moving forward with an expanded AM-111 late-stage clinical development program. The... More
